Select Page

Cameroon

The Cameroon Population-based HIV Impact Assessment (CAMPHIA) began fieldwork in June 2017 and concluded in January 2018.

Survey teams visited over 12,000 households, interviewed participants, and provided HIV counseling and testing.

Cameroon

The Cameroon Population-based HIV Impact Assessment (CAMPHIA) began fieldwork in June 2017 and concluded in January 2018.

CAMPHIA teams worked in all 10 regions of Cameroon under the guidance of the Ministry of Health, the National Institute of Statistics, CDC, and ICAP to provide confidential HIV counseling and testing to participants.

Details on the findings, announced at AIDS 2018 in Amsterdam, can be found below.

Key Findings

%

Annual HIV incidence among adults

%

HIV prevalence among adults

%

Viral load suppression among adults living with HIV*

90-90-90 among adults living with HIV
20%

Adults living with HIV knew their HIV status

75%

Adults who were aware of their HIV status were on ART

75%

Adults who were on ART had viral load suppression

CAMPHIA Video (Do your test)

Recent PHIA News
Data Collection Begins for First PHIA Survey
Data Collection Begins for First PHIA Survey
The groundbreaking Zimbabwe Population-based HIV Impact Assessment (ZIMPHIA) survey enrolled its first participants on October 18th, with 12 ZIMPHIA field teams kicking off data collection in the northern region of Zimbabwe.
Major HIV Assessment Launches in Zimbabwe
Major HIV Assessment Launches in Zimbabwe
On September 18th, the Zimbabwe Population-based HIV Impact Assessment (ZIMPHIA) was formally launched in Harare by Zimbabwe’s Ministry of Health and Child Care, the National AIDS Council, the Ambassador of the Government of the United States of America, and representatives of PEPFAR, CDC, ICAP at Columbia University, and other project partners.
ICAP to lead large population-based HIV surveys in 20 African countries
ICAP to lead large population-based HIV surveys in 20 African countries
ICAP at Columbia University has received $25 million in the first year of a $125 million, five-year award from the U.S. Centers for Disease Control and Prevention to conduct national, population-based HIV impact assessments (PHIAs) in 20 countries in sub-Saharan Africa.